NO991150L - Pyrazolopyrimidiner og pyrazolotriaziner - Google Patents

Pyrazolopyrimidiner og pyrazolotriaziner

Info

Publication number: NO991150L
Authority: NO; Norway
Prior art keywords: pyrazolotriazines; pyrazolopyrimidines
Prior art date: 1998-03-11

Application number

NO991150A

Other languages

English (en)

Other versions

NO991150D0 (no

NO312297B1 (no

Inventor

Michael Boes

Claus Riemer

Heinz Stadler

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-11

Filing date

1999-03-10

Publication date

1999-09-13

1999-03-10 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1999-03-10 Publication of NO991150D0 publication Critical patent/NO991150D0/no

1999-09-13 Publication of NO991150L publication Critical patent/NO991150L/no

2002-04-22 Publication of NO312297B1 publication Critical patent/NO312297B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO19991150A 1998-03-11 1999-03-10 Pyrazolopyrimidiner og pyrazolotriaziner, anvendelse og fremgangsmåte for fremstilling derav, samt medikament NO312297B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98104346		1998-03-11

Publications (3)

Publication Number	Publication Date
NO991150D0 NO991150D0 (no)	1999-03-10
NO991150L true NO991150L (no)	1999-09-13
NO312297B1 NO312297B1 (no)	2002-04-22

Family

ID=8231568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19991150A NO312297B1 (no)	1998-03-11	1999-03-10	Pyrazolopyrimidiner og pyrazolotriaziner, anvendelse og fremgangsmåte for fremstilling derav, samt medikament

Country Status (33)

Country	Link
US (1)	US6194410B1 (no)
EP (1)	EP0941994B1 (no)
JP (1)	JP3231288B2 (no)
KR (1)	KR100313181B1 (no)
CN (1)	CN1118468C (no)
AR (1)	AR016453A1 (no)
AT (1)	ATE240332T1 (no)
AU (1)	AU752408B2 (no)
BR (1)	BR9901095A (no)
CA (1)	CA2265095C (no)
CZ (1)	CZ291514B6 (no)
DE (1)	DE69907784T2 (no)
DK (1)	DK0941994T3 (no)
ES (1)	ES2198095T3 (no)
HR (1)	HRP990077B1 (no)
HU (1)	HUP9900589A1 (no)
ID (1)	ID23575A (no)
IL (1)	IL128869A (no)
MA (1)	MA26612A1 (no)
MY (1)	MY119536A (no)
NO (1)	NO312297B1 (no)
NZ (1)	NZ334526A (no)
PE (1)	PE20000337A1 (no)
PL (1)	PL331875A1 (no)
PT (1)	PT941994E (no)
RU (1)	RU2218340C2 (no)
SG (1)	SG78336A1 (no)
SI (1)	SI0941994T1 (no)
TR (1)	TR199900531A3 (no)
TW (1)	TW585865B (no)
UY (1)	UY25419A1 (no)
YU (1)	YU12099A (no)
ZA (1)	ZA991946B (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4331500A (en) *	1999-04-06	2000-10-23	Du Pont Pharmaceuticals Company	Pyrazolotriazines as crf antagonists
DE19956791A1 (de) *	1999-11-25	2001-05-31	Merck Patent Gmbh	Neue Sulfonyloxazolamine
PE20020394A1 (es)	2000-08-18	2002-06-21	Agouron Pharma	Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
ES2282401T3 (es) *	2001-03-13	2007-10-16	Bristol-Myers Squibb Pharma Company	4-(2-butilamino)-2,7-dimetil-8-(2-metil-6-metoxipirid-3-il) pirazolo - 1,5-a-1,3,5-triazina, sus enantiomeros y sales farmaceuticamente aceptables como ligandos del receptor del factor liberador de croticotropina.
DE60218037T2 (de)	2001-06-07	2007-08-23	F. Hoffmann-La Roche Ag	Neue indolderivate mit affinität zum 5-ht6-rezeptor
BR0210411A (pt)	2001-06-15	2004-08-17	Hoffmann La Roche	Derivados 4-piperazinilindol com afinidade para o receptor 5-ht6
JP2005527463A (ja) *	2001-08-07	2005-09-15	スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー	Ｃｎｓ疾患を治療するための５−ｈｔ６受容体アフィニティーを有する３−アリールスルホニル−７−ピペラジニル−インドール、−ベンゾフランおよび−ベンゾチオフェン
PT1455779E (pt) *	2001-12-20	2006-11-30	Wyeth Corp	Derivados de indolilalquilamina como ligandos da 5-hidroxitriptamina-6
US6642381B2 (en) *	2001-12-27	2003-11-04	Hoffman-La Roche Inc.	Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
GB0202679D0 (en) *	2002-02-05	2002-03-20	Glaxo Group Ltd	Novel compounds
UA78999C2 (en) *	2002-06-04	2007-05-10	Wyeth Corp	1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
US6875771B2 (en)	2002-07-26	2005-04-05	Bristol-Myers Squibb Company	Pyridopyrimidine derivatives as 5-HT6 antagonists
US7196078B2 (en) *	2002-09-04	2007-03-27	Schering Corpoartion	Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
MY138201A (en) *	2002-09-04	2009-05-29	Schering Corp	Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7329658B2 (en) *	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
MXPA05008441A (es) *	2003-02-14	2005-10-19	Wyeth Corp	Derivados de heterociclil-3-sulfonilindazol o azaindazol como ligandos de 5-hidroxitriptamina-6.
KR20050115252A (ko)	2003-02-28	2005-12-07	데이진 화-마 가부시키가이샤	피라졸로[1,5-ａ]피리미딘 유도체
GB0305559D0 (en) *	2003-03-11	2003-04-16	Teijin Ltd	Compounds
US7585881B2 (en) *	2004-02-18	2009-09-08	Astrazeneca Ab	Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
US20080287405A1 (en) *	2004-05-14	2008-11-20	Thannickal Victor J	Compositions and Methods Relating to Protein Kinase Inhibitors
MX337817B (es) *	2004-11-04	2011-11-04	Vertex Pharma	Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas.
RU2390523C2 (ru) *	2005-10-21	2010-05-27	Мицубиси Танабе Фарма Корпорейшн	ПРОИЗВОДНОЕ ПИРАЗОЛ[1,5-a]ПИРИМИДИНА
RU2330854C2 (ru) *	2006-03-15	2008-08-10	Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУВПО "ПГФА Росздрава")	Способ получения конденсированных гем-диметилзамещенных амино-1,3,5-триазинов
EP2248817B1 (en) *	2008-01-24	2015-01-07	Alla Chem, LLC.	Substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
EP2248814A4 (en) *	2008-01-24	2011-01-12	Alla Chem Llc	SUBSTITUTED CYCLOALKAN [E AND D] PYRAZOLO [1,5-A] PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND PROCESS FOR THEIR PREPARATION AND THEIR USE
RU2369600C1 (ru) *	2008-01-24	2009-10-10	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 4-СУЛЬФОНИЛ-ПИРАЗОЛЫ И 3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ5-HT6 РЕЦЕПТОРОВ, АКТИВНЫЙ КОМПОНЕНТ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЛЕКАРСТВЕННОЕ СРЕДСТВО И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
JP5584626B2 (ja) *	2008-01-24	2014-09-03	アンドレイ・アレクサンドロビッチ・イワシェンコ	２−アルキルアミノ−３−（アリールスルホニル）−シクロアルキル［ｅ又はｄ］ピラゾロ［１，５−ａ］ピリミジン−セロトニン５−ＨＴ６受容体アンタゴニスト、その調製の方法及び使用
RU2384581C2 (ru)	2008-05-07	2010-03-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 2-АМИНО-3-СУЛЬФОНИЛ-ТЕТРАГИДРО-ПИРАЗОЛО[1,5-a]ПИРИДО-ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
EP3020719B1 (en)	2008-10-06	2017-09-20	Alla Chem, LLC.	Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof and methods for the production and use thereof
EP2384328B1 (en)	2008-11-27	2013-02-13	Boehringer Ingelheim International GmbH	6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and process for preparing them
GB0908394D0 (en)	2009-05-15	2009-06-24	Univ Leuven Kath	Novel viral replication inhibitors
GB0913636D0 (en)	2009-08-05	2009-09-16	Univ Leuven Kath	Novel viral replication inhibitors
JP2013542243A (ja)	2010-11-15	2013-11-21	カトリーケウニヴェルシテイトルーヴェン	新規な抗ウイルス性化合物
RU2443697C1 (ru)	2010-12-21	2012-02-27	Александр Васильевич Иващенко	Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения
CN104023728B (zh)	2011-09-30	2016-11-02	益普生制药股份有限公司	大环lrrk2激酶抑制剂
MX381849B (es) *	2012-03-09	2025-03-13	Lexicon Pharmaceuticals Inc	Compuestos a base de pirazol[1,5-a]pirimidina, composiciones que los comprenden, y métodos para su uso.
TW201542550A (zh) *	2013-09-06	2015-11-16	Lexicon Pharmaceuticals Inc	吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
TW201620911A (zh) *	2014-03-17	2016-06-16	雷西肯製藥股份有限公司	銜接子關聯激酶１之抑制劑、包含其之組成物、及其使用方法
CA2960777A1 (en)	2014-09-17	2016-03-24	Oncodesign S.A.	Macrocyclic lrrk2 kinase inhibitors
EP3268000B1 (en)	2015-03-09	2021-08-04	Aurigene Discovery Technologies Limited	Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
WO2017052394A1 (en) *	2015-09-23	2017-03-30	Uniwersytet Jagielloński	Imidazopyridine compounds and their use as 5-ht6 receptor ligands
EP3371188B1 (en)	2015-11-02	2019-10-23	Janssen Pharmaceutica NV	[1,2,4]triazolo[1,5-a]pyrimidin-7-yl compound
TWI764950B (zh)	2016-11-02	2022-05-21	比利時商健生藥品公司	Ｐｄｅ２抑制劑
CN109890824B (zh)	2016-11-02	2022-05-24	詹森药业有限公司	作为pde2抑制剂的[1,2,4]三唑并[1,5-a]嘧啶化合物
AU2017353315B2 (en)	2016-11-02	2021-09-16	Janssen Pharmaceutica Nv	(1,2,4)triazolo(1,5-a)pyrimidine compounds as PDE2 inhibitors
MA55909A (fr)	2019-05-05	2022-03-16	Qilu Regor Therapeutics Inc	Inhibiteurs de cdk
CN112142744A (zh) *	2019-06-28	2020-12-29	上海瑛派药业有限公司	取代的稠合杂芳双环化合物作为激酶抑制剂及其应用
PH12022551623A1 (en)	2020-01-13	2023-11-29	Verge Analytics Inc	Substituted pyrazolo-pyrimidines and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3907799A (en) *	1971-08-16	1975-09-23	Icn Pharmaceuticals	Xanthine oxidase inhibitors
EP0368897A1 (en)	1987-07-31	1990-05-23	E.I. Du Pont De Nemours And Company	Herbicidal sulfonamides
US4921527A (en) *	1987-07-31	1990-05-01	E. I. Du Pont De Nemours And Company	Herbicidal sulfonamides
DE3825043A1 (de)	1988-07-20	1990-02-15	Schering Ag	3-methylsulfonyl-pyrazolo(1,5-a)pyrimidin-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, pflanzenwuchsregulierender und fungizider wirkung
US5571813A (en) *	1993-06-10	1996-11-05	Beiersdorf-Lilly Gmbh	Fused pyrimidine compounds and their use as pharmaceuticals
AU7001396A (en)	1995-09-22	1997-04-09	Takeda Chemical Industries Ltd.	Triazole compounds, their production and use
JP2001506995A (ja)	1996-12-19	2001-05-29	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	Ｎ−ピペラジン−１−イルフェニル−ベンズアミド誘導体
DZ2376A1 (fr)	1996-12-19	2002-12-28	Smithkline Beecham Plc	Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
ATE296811T1 (de)	1997-07-11	2005-06-15	Smithkline Beecham Plc	Sulfonamid-derivate als 5-ht6 receptor antagonisten und verfahren zu ihrer herstellung

1999
- 1999-02-24 US US09/256,927 patent/US6194410B1/en not_active Expired - Fee Related
- 1999-03-03 DE DE69907784T patent/DE69907784T2/de not_active Expired - Fee Related
- 1999-03-03 EP EP99102872A patent/EP0941994B1/en not_active Expired - Lifetime
- 1999-03-03 AT AT99102872T patent/ATE240332T1/de not_active IP Right Cessation
- 1999-03-03 PT PT99102872T patent/PT941994E/pt unknown
- 1999-03-03 SI SI9930320T patent/SI0941994T1/xx unknown
- 1999-03-03 ES ES99102872T patent/ES2198095T3/es not_active Expired - Lifetime
- 1999-03-03 DK DK99102872T patent/DK0941994T3/da active
- 1999-03-08 NZ NZ334526A patent/NZ334526A/xx unknown
- 1999-03-08 YU YU12099A patent/YU12099A/sh unknown
- 1999-03-08 PE PE1999000183A patent/PE20000337A1/es not_active Application Discontinuation
- 1999-03-08 IL IL12886999A patent/IL128869A/xx not_active IP Right Cessation
- 1999-03-08 CA CA002265095A patent/CA2265095C/en not_active Expired - Fee Related
- 1999-03-08 MA MA25485A patent/MA26612A1/fr unknown
- 1999-03-09 MY MYPI99000853A patent/MY119536A/en unknown
- 1999-03-09 UY UY25419A patent/UY25419A1/es unknown
- 1999-03-09 AR ARP990100990A patent/AR016453A1/es unknown
- 1999-03-09 JP JP06114999A patent/JP3231288B2/ja not_active Expired - Fee Related
- 1999-03-09 SG SG1999001080A patent/SG78336A1/en unknown
- 1999-03-10 ZA ZA9901946A patent/ZA991946B/xx unknown
- 1999-03-10 RU RU99105137/04A patent/RU2218340C2/ru active
- 1999-03-10 TW TW088103692A patent/TW585865B/zh not_active IP Right Cessation
- 1999-03-10 CZ CZ1999825A patent/CZ291514B6/cs not_active IP Right Cessation
- 1999-03-10 ID IDP990198D patent/ID23575A/id unknown
- 1999-03-10 PL PL99331875A patent/PL331875A1/xx unknown
- 1999-03-10 NO NO19991150A patent/NO312297B1/no unknown
- 1999-03-10 HU HU9900589A patent/HUP9900589A1/hu not_active Application Discontinuation
- 1999-03-10 KR KR1019990007881A patent/KR100313181B1/ko not_active Expired - Fee Related
- 1999-03-10 BR BR9901095-0A patent/BR9901095A/pt not_active Application Discontinuation
- 1999-03-11 HR HR990077A patent/HRP990077B1/xx not_active IP Right Cessation
- 1999-03-11 TR TR1999/00531A patent/TR199900531A3/tr unknown
- 1999-03-11 AU AU20383/99A patent/AU752408B2/en not_active Ceased
- 1999-03-11 CN CN99105964A patent/CN1118468C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HRP990077A2 (en)	2000-02-29
CA2265095C (en)	2008-07-22
EP0941994B1 (en)	2003-05-14
DE69907784D1 (de)	2003-06-18
SG78336A1 (en)	2001-02-20
CN1118468C (zh)	2003-08-20
SI0941994T1 (en)	2003-10-31
AU752408B2 (en)	2002-09-19
BR9901095A (pt)	2000-05-02
TR199900531A2 (xx)	1999-10-21
UY25419A1 (es)	2001-11-30
PE20000337A1 (es)	2000-05-13
TW585865B (en)	2004-05-01
CN1236780A (zh)	1999-12-01
ZA991946B (en)	1999-09-13
JP3231288B2 (ja)	2001-11-19
IL128869A (en)	2003-09-17
KR19990077741A (ko)	1999-10-25
CZ82599A3 (cs)	1999-09-15
MA26612A1 (fr)	2004-12-20
NO991150D0 (no)	1999-03-10
TR199900531A3 (tr)	1999-10-21
IL128869A0 (en)	2000-01-31
KR100313181B1 (ko)	2001-11-05
NO312297B1 (no)	2002-04-22
PT941994E (pt)	2003-09-30
EP0941994A1 (en)	1999-09-15
HK1023343A1 (en)	2000-09-08
ID23575A (id)	2000-05-04
HUP9900589A1 (hu)	2000-03-28
JP2000186090A (ja)	2000-07-04
MY119536A (en)	2005-06-30
CA2265095A1 (en)	1999-09-11
PL331875A1 (en)	1999-09-13
DE69907784T2 (de)	2004-03-25
HRP990077B1 (en)	2003-08-31
AR016453A1 (es)	2001-07-04
RU2218340C2 (ru)	2003-12-10
NZ334526A (en)	2000-07-28
YU12099A (sh)	2000-10-30
HU9900589D0 (en)	1999-05-28
AU2038399A (en)	1999-09-23
US6194410B1 (en)	2001-02-27
ES2198095T3 (es)	2004-01-16
CZ291514B6 (cs)	2003-03-12
DK0941994T3 (da)	2003-09-08
ATE240332T1 (de)	2003-05-15

Publication	Publication Date	Title
NO991150L (no)	1999-09-13	Pyrazolopyrimidiner og pyrazolotriaziner
DK1454907T3 (da)	2009-03-09	Quninazolin og pyridopyrmidin-derivativer
NO20032753L (no)	1999-12-13	Forbindelse og anvendelse derav
DK0915880T3 (da)	2008-02-11	Azolotriaziner og pyrimidiner
DK0815861T3 (da)	2002-01-21	Sulfonamider og anvendelse deraf
IS4481A (is)	1997-05-12	Díhýdrópyramídín og notkun þeirra
ID24555A (id)	2000-07-27	Popok sekali pakai
ID23076A (id)	2000-02-03	Popok sekali pakai
DE69836432D1 (de)	2006-12-28	Bildcoder und -decoder
DE69909284D1 (de)	2003-08-07	Verbesserungen bei koaleszierfilter
ATE220304T1 (de)	2002-07-15	Servier- und transportaufnahme
NO20006488D0 (no)	2000-12-19	Sammensetning og anvendelse
BR9506832A (pt)	1997-10-14	N-pirazolilanilinas e n-pirazolilaminopiridinas
ID23083A (id)	2000-02-03	Popok sekali pakai
NO986174D0 (no)	1998-12-29	Triazinderivater og anvendelse derav
DE69916694D1 (de)	2004-06-03	2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
NO964541L (no)	1996-12-23	Porphacyanin og CNC-utvidete porphyriner
DK1140952T3 (da)	2004-01-12	Phosphororganiske forbindelser og anvendelse heraf
FI974044A0 (fi)	1997-10-24	Spis
NO20003268L (no)	2000-08-15	Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
FI972010A0 (fi)	1997-05-13	Arrangemang i en borrningsanordning
DE59812220D1 (de)	2009-06-04	Halte- und trageband
FI980691A0 (fi)	1998-03-26	Xylitoltillsats i roektobak
FI964475A0 (fi)	1996-11-07	Kombinerat cellular- och rundradionaet
NO307128B1 (no)	2000-02-14	Katamaran og trimaranski